- Category :
- Manufacturer : Cipla Ltd.
- Description : NEVIMUNE Tablets : ................. Contains blister of 10 tablets
Additional important information regarding the use of nevirapine for the treatment of HIV-1 infection is given below Based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled studies, NEVIMUNE should not be initiated in adult females with CD4+ cell counts greater than 250 cells/mm 3 or in adult males with CD4+ cell counts greater than 400 cells/mm 3 unless the benefit outweighs the risk
- Indication : NEVIMUNE is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection.
- Strength : 200 mg
The content presented on the MILI HEALTHCARE website is presented solely for informational purposes.
